Moreover, in cancer cells, TRPV4 facilitates metastatic progression by modulating actomyosin contractility and cell stiffness through Ca2+-dependent activation of the AKT–E-cadherin pathway, ultimately enhancing transendothelial migration and the invasive potential of tumor cell [51]. Here, TRPV4 is linked to neoplasm.